Zurcher Kantonalbank (Zurich Cantonalbank) Dexcom Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$33.8 Billion
Q1 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Dexcom Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 237,859 shares of DXCM stock, worth $17.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

237,859

Previous 198,648 19.74%

Holding current value

$17.9 Million

Previous $15.4 Million 5.15%

% of portfolio

0.05%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$67.74 - $90.75 $2.66 Million - $3.56 Million	39,211 Added 19.74%	237,859 $16.2 Million
Q4 2024 Feb 07, 2025	BUY	$65.68 - $81.01 $3.49 Million - $4.31 Million	53,158 Added 36.54%	198,648 $15.4 Million
Q3 2024 Nov 07, 2024	SELL	$64.0 - $116.06 $144,064 - $261,251	-2,251 Reduced 1.52%	145,490 $9.75 Million
Q2 2024 Jul 29, 2024	BUY	$110.31 - $140.45 $1.31 Million - $1.66 Million	11,846 Added 8.72%	147,741 $16.8 Million
Q1 2024 Apr 25, 2024	BUY	$114.22 - $140.1 $422,042 - $517,669	3,695 Added 2.8%	135,895 $18.8 Million
Q4 2023 Jan 30, 2024	BUY	$75.49 - $124.16 $3.48 Million - $5.72 Million	46,062 Added 53.47%	132,200 $16.4 Million
Q3 2023 Oct 25, 2023	SELL	$86.06 - $137.93 $7.02 Million - $11.2 Million	-81,525 Reduced 48.62%	86,138 $8.04 Million
Q2 2023 Aug 07, 2023	BUY	$112.47 - $130.98 $7.45 Million - $8.68 Million	66,258 Added 65.34%	167,663 $21.5 Million
Q1 2023 May 08, 2023	BUY	$104.0 - $122.92 $2.65 Million - $3.13 Million	25,435 Added 33.48%	101,405 $11.8 Million
Q4 2022 Feb 01, 2023	SELL	$84.98 - $122.67 $290,546 - $419,408	-3,419 Reduced 4.31%	75,970 $8.6 Million
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $1.32 Million - $1.62 Million	17,242 Added 27.74%	79,389 $6.39 Million
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $2.53 Million - $4.95 Million	37,225 Added 149.37%	62,147 $4.63 Million
Q1 2022 Apr 21, 2022	BUY	$94.08 - $130.2 $344,332 - $476,531	3,660 Added 17.21%	24,922 $12.8 Million
Q4 2021 Feb 01, 2022	BUY	$129.87 - $162.82 $602,726 - $755,647	4,641 Added 27.92%	21,262 $11.4 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $773,220 - $1.04 Million	-7,246 Reduced 30.36%	16,621 $9.09 Million
Q2 2021 Jul 30, 2021	SELL	$80.99 - $107.93 $236,814 - $315,587	-2,924 Reduced 10.91%	23,867 $10.2 Million
Q1 2021 May 03, 2021	BUY	$84.79 - $104.74 $12,040 - $14,873	142 Added 0.53%	26,791 $9.63 Million
Q4 2020 Jan 28, 2021	SELL	$78.0 - $104.5 $65,988 - $88,407	-846 Reduced 3.08%	26,649 $9.85 Million
Q3 2020 Nov 06, 2020	BUY	$95.51 - $112.95 $233,426 - $276,049	2,444 Added 9.76%	27,495 $11.3 Million
Q2 2020 Jul 28, 2020	BUY	$62.68 - $105.34 $198,256 - $333,190	3,163 Added 14.45%	25,051 $10.2 Million
Q1 2020 May 06, 2020	BUY	$47.79 - $75.63 $128,841 - $203,898	2,696 Added 14.05%	21,888 $5.89 Million
Q4 2019 Jan 21, 2020	SELL	$36.62 - $57.29 $46,434 - $72,643	-1,268 Reduced 6.2%	19,192 $4.2 Million
Q3 2019 Oct 18, 2019	BUY	$35.53 - $43.8 $15,952 - $19,666	449 Added 2.24%	20,460 $3.05 Million
Q1 2019 Apr 29, 2019	BUY	$28.07 - $38.18 $44,771 - $60,897	1,595 Added 8.66%	20,011 $2.38 Million
Q4 2018 Jan 25, 2019	BUY	$26.99 - $37.37 $343,555 - $475,682	12,729 Added 223.83%	18,416 $2.21 Million
Q3 2018 Nov 09, 2018	BUY	$23.35 - $36.72 $3,152 - $4,957	135 Added 2.43%	5,687 $813,000
Q2 2018 Aug 06, 2018	BUY	$17.54 - $25.22 $8,261 - $11,878	471 Added 9.27%	5,552 $527,000
Q1 2018 May 03, 2018	BUY	$13.06 - $18.54 $6,987 - $9,918	535 Added 11.77%	5,081 $377,000
Q4 2017 Jan 31, 2018	SELL	$11.12 - $15.38 $153,111 - $211,767	-13,769 Reduced 75.18%	4,546 $261,000
Q3 2017 Nov 08, 2017	BUY	$11.36 - $18.98 $208,058 - $347,618	18,315	18,315 $896,000

Others Institutions Holding DXCM

# of Institutions

1,094

Shares Held

364M

Call Options Held

5.74M

Put Options Held

4.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Dexcom Inc Transaction History